These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12432242)

  • 1. The role of ubiquitin-proteasome pathway in oncogenic signaling.
    Fuchs SY
    Cancer Biol Ther; 2002; 1(4):337-41. PubMed ID: 12432242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.
    Easwaran V; Song V; Polakis P; Byers S
    J Biol Chem; 1999 Jun; 274(23):16641-5. PubMed ID: 10347231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the constitutive and inducible degradation of Smad3 by the ubiquitin-proteasome pathway to transforming growth factor-beta signaling.
    Inoue Y; Kitagawa M; Onozaki K; Hayashi H
    J Interferon Cytokine Res; 2004 Jan; 24(1):43-54. PubMed ID: 14980084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system.
    Sadot E; Simcha I; Iwai K; Ciechanover A; Geiger B; Ben-Ze'ev A
    Oncogene; 2000 Apr; 19(16):1992-2001. PubMed ID: 10803460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor viruses and cell signaling pathways: deubiquitination versus ubiquitination.
    Shackelford J; Pagano JS
    Mol Cell Biol; 2004 Jun; 24(12):5089-93. PubMed ID: 15169876
    [No Abstract]   [Full Text] [Related]  

  • 6. On and off: proteasome and TGF-beta signaling.
    Zhang F; Laiho M
    Exp Cell Res; 2003 Dec; 291(2):275-81. PubMed ID: 14644150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-catenin is a target for the ubiquitin-proteasome pathway.
    Aberle H; Bauer A; Stappert J; Kispert A; Kemler R
    EMBO J; 1997 Jul; 16(13):3797-804. PubMed ID: 9233789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin signalling: what's in a chain?
    Hochstrasser M
    Nat Cell Biol; 2004 Jul; 6(7):571-2. PubMed ID: 15232583
    [No Abstract]   [Full Text] [Related]  

  • 9. Atrophin-1-interacting protein 4/human Itch is a ubiquitin E3 ligase for human enhancer of filamentation 1 in transforming growth factor-beta signaling pathways.
    Feng L; Guedes S; Wang T
    J Biol Chem; 2004 Jul; 279(28):29681-90. PubMed ID: 15051726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach.
    Amit S; Ben-Neriah Y
    Semin Cancer Biol; 2003 Feb; 13(1):15-28. PubMed ID: 12507553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium.
    Stewart D; Killeen E; Naquin R; Alam S; Alam J
    J Biol Chem; 2003 Jan; 278(4):2396-402. PubMed ID: 12441344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel in vitro assay for deubiquitination of I kappa B alpha.
    Strayhorn WD; Wadzinski BE
    Arch Biochem Biophys; 2002 Apr; 400(1):76-84. PubMed ID: 11913973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Smad pathway.
    Wrana JL; Attisano L
    Cytokine Growth Factor Rev; 2000; 11(1-2):5-13. PubMed ID: 10708948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
    Xu J; Attisano L
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin-proteasome pathway.
    Roos-Mattjus P; Sistonen L
    Ann Med; 2004; 36(4):285-95. PubMed ID: 15224655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2.
    Liang M; Liang YY; Wrighton K; Ungermannova D; Wang XP; Brunicardi FC; Liu X; Feng XH; Lin X
    Mol Cell Biol; 2004 Sep; 24(17):7524-37. PubMed ID: 15314162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus activates beta-catenin in type III latently infected B lymphocyte lines: association with deubiquitinating enzymes.
    Shackelford J; Maier C; Pagano JS
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15572-6. PubMed ID: 14663138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell biology. Chemical genetics hits.
    Bellows DS; Tyers M
    Science; 2004 Oct; 306(5693):67-8. PubMed ID: 15459377
    [No Abstract]   [Full Text] [Related]  

  • 19. Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis.
    Moldes M; Zuo Y; Morrison RF; Silva D; Park BH; Liu J; Farmer SR
    Biochem J; 2003 Dec; 376(Pt 3):607-13. PubMed ID: 12954078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins.
    Fukuchi M; Imamura T; Chiba T; Ebisawa T; Kawabata M; Tanaka K; Miyazono K
    Mol Biol Cell; 2001 May; 12(5):1431-43. PubMed ID: 11359933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.